Professional Summary
Professional Overview
Ben Porebski is the Co-founder, CEO/CTO of Sortera Bio, a Cambridge-based biotechnology company. With a diverse background spanning scientific research, engineering, and entrepreneurship, he brings a unique blend of technical expertise and business acumen to the role.
Experience Summary
Current Role
As the Co-founder, CEO/CTO of Sortera Bio, Ben is responsible for driving the company's strategic vision and overseeing the development of its innovative biotechnology solutions. In this role, he leverages his deep understanding of molecular biology, bioinformatics, and process engineering to guide the company's product roadmap and ensure the delivery of cutting-edge technologies.
Career Progression
Prior to co-founding Sortera Bio, Ben held prestigious positions as an Investigator Scientist and Postdoctoral Research Fellow at the MRC Laboratory of Molecular Biology (LMB) in the United Kingdom. In these roles, he conducted groundbreaking research in the fields of molecular biology and bioinformatics, contributing to advancing scientific knowledge and developing novel experimental techniques.
Before embarking on his scientific career, Ben served in the Australian Army as a Signals officer, where he honed his leadership skills and problem-solving abilities in a high-stakes, multifaceted environment.
Academic Background
Ben holds a Ph.D. in Molecular Biology from the University of Cambridge, where he specialized in the development of novel bioinformatics algorithms and their application to the study of genetic regulation and protein structure-function relationships.
Areas of Expertise
- Molecular biology and bioinformatics
- Biotechnology product development
- Process engineering and optimization
- Entrepreneurship and business strategy
- Technical leadership and team management
Professional Impact
Throughout his career, Ben has been recognized for his contributions to the scientific community, having published numerous peer-reviewed articles in prestigious journals and presented his research at leading industry conferences. As the Co-founder and CEO/CTO of Sortera Bio, he is poised to make a significant impact on the biotechnology industry by driving the development and commercialization of innovative solutions that address pressing challenges in the field.
Conclusion
With his exceptional technical expertise, entrepreneurial mindset, and proven leadership skills, Ben Porebski is well-positioned to guide Sortera Bio to new heights and make a lasting impact on the biotechnology landscape.
